WordNet

the market value set on assets
an amount determined as payable; "the assessment for repairs outraged the clubs membership"
requiring or amenable to treatment by medicine especially as opposed to surgery; "medical treatment"; "pneumonia is a medical disease"
relating to the study or practice of medicine; "the medical profession"; "a medical student"; "medical school"
the practical application of science to commerce or industry (同)engineering
any of several Old World herbs of the genus Medicago having small flowers and trifoliate compound leaves (同)medick, trefoil

PrepTutorEJDIC

〈U〉評価,査定;(環境などの)状況判定 / 〈C〉評価額,課税額
『医学の』,医術の;医者の / 内科の;内科治療を要する / 診察
科学技術,工業技術・科学(工業)技術的な方法(過程)・文明の環境利用(開発)・応用科学; 専門用語
医学生,インターン / 医学関係者;《特に米》衛生兵,看護兵

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/10/23 04:21:03」(JST)

wiki en

Medical technology assessment (MTA) is the objective evaluation of a medical technology regarding its safety and performance, its (future) impact on clinical and non-clinical patient outcomes as well as its interactive effects on economical, organizational, social, juridical and ethical aspects of healthcare. Medical technologies are assessed both in absolute terms and in comparison to other (combinations of) medical technologies, procedures, treatments or ‘doing-nothing’.

The aim of MTA is to provide objective, high-quality information that relevant stakeholders use for decision-making about for example development, pricing, market access and reimbursement of new medical technologies. As such, MTA is similar to health technology assessment (HTA), except that HTA has a wider scope and may include assessments of for example organizational or financial interventions.

The classical approach of MTA is to evaluate technologies after they enter the marketplace. Yet, a growing number of researchers and policy-makers argue that new technologies should be evaluated before they diffuse into routine clinical practice.^[1] MTA of biomedical innovations in a very early stage of development could improve health outcomes, minimise wrong investment and prevent social and ethical conflicts.^[2]

One particular method within the area of early MTA is constructive technology assessment (CTA). CTA is particularly appropriate for the early assessment of dynamic technologies that are implemented under uncertain circumstances. CTA is based on the idea that during the course of technology development, choices are constantly being made about the form, the function, and the use of that technology. Especially in early stages, technologies are not always stable, nor are its specifications and neither is its use, as both technology and environment will mutually influence each other. In recent years, CTA has developed from assessing the (clinical) impact of a new technology to a much broader approach, including the analysis of design, development, and implementation of that new technology.^[3]

In the Netherlands, the department Health Technology and Services Research (HTSR) of the University of Twente performs early MTA and CTA in collaboration with technology users (patients, healthcare professionals), technology developers (academic and industrial), technology investors (venture capitalists, government, etc.) technology procurers (hospitals, patients, etc.) and decision-makers in healthcare (patients, policy-makers etc.) By performing excellent scientific research, that is valuable and relevant for society, HTSR aims to support decisions about early development and implementation of health care technology in order to achieve high quality healthcare for individual patients. Examples of the research of HTSR include the early economic evaluation of neuromuscular electrical stimulation in the treatment of shoulder pain and early phase technology assessment of nanotechnology in oncology.^[4]^[5]

References

^ Vallejo-Torres L, Steuten LM, Buxton MJ, Girling AJ, Lilford RJ, Young T. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach. International Journal of Technology Assessment in Health Care. 2008 Fall;24(4):459–64.
^ Pietzsch JB, Paté-Cornell ME. Early technology assessment of new medical devices. International Journal of Technology Assessment in Health Care, 24:1 (2008), 36–44.
^ Douma KF, Karsenberg K, Hummel MJ, Bueno-de-Mesquita, van Harten WH. Methodology of Constructive Technology Assessment in health care. International Journal of Technology Assessment in Health Care, 23:2 (2007), 162–8.
^ Van Til JA, Renzenbrink GJ, Groothuis K, Ijzerman MJ. A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain. Disability Rehabilitation, 30:28 (2006), 645–51.
^ Retèl VP, Hummel MJ, van Harten WH. Early phase Technology Assessment of nanotechnology in oncology. Tumori, 94:2 (2008), 284–90.

External links

Health Technology and Services Research – University of Twente (NL)
Eucomed
NICE Evaluation Pathway Programme for Medical Technologies
Multidisciplinary Assessment of Technology Centre for Healthcare
Canadian Agency for Drugs and Technologies in Health – Medical Devices and Health Systems projects
Health Technology Assessment International
International Society for Pharmacoeconomics and Outcomes Research

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 緩和ケアにおける症状の評価へのアプローチ approach to symptom assessment in palliative care
2. 緩和ケアにおける包括的患者評価の概要 overview of comprehensive patient assessment in palliative care
3. 高齢者の職場健康診断 office based assessment of the older adult
4. 包括的老年医学的評価 comprehensive geriatric assessment
5. 幼児および小児における視覚の発達および視力評価 visual development and vision assessment in infants and children

English Journal

Quantitative analysis of facial palsy using a three-dimensional facial motion measurement system.

Katsumi S1, Esaki S2, Hattori K3, Yamano K1, Umezaki T4, Murakami S1.
Auris, nasus, larynx.Auris Nasus Larynx.2015 Aug;42(4):275-83. doi: 10.1016/j.anl.2015.01.002. Epub 2015 Feb 2.
OBJECTIVE: The prognosis for facial nerve palsy (FNP) depends on its severity. Currently, many clinicians use the Yanagihara, House-Brackmann, and/or Sunnybrook grading systems to assess FNP. Although these assessments are performed by experts, inter- and intra-observer disagreements have been demon
PMID 25655983

An attempt to bridge muscle architecture dynamics and its instantaneous rate of force development using ultrasonography.

Li J1, Zhou Y2, Zheng YP3, Li G4.
Ultrasonics.Ultrasonics.2015 Aug;61:71-8. doi: 10.1016/j.ultras.2015.03.009. Epub 2015 Apr 4.
Muscle force output is an essential index in rehabilitation assessment or physical exams, and could provide considerable insights for various applications such as load monitoring and muscle assessment in sports science or rehabilitation therapy. Besides direct measurement of force output using a dyn
PMID 25911147

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia.

Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD 3rd, Chen K, Wang JC, Wen W, Cawthon R, Chatterjee N, Hu W, Caporaso NE, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein RJ, Chung CC, Oh IJ, Chen KY, Berndt SI, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen RC, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wong MP, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Zheng W, Lin D, Chanock SJ, Rothman N, Lan Q.
International journal of cancer. Journal international du cancer.Int J Cancer.2015 Jul 15;137(2):311-9. doi: 10.1002/ijc.29393. Epub 2014 Dec 29.
Recent evidence from several relatively small nested case-control studies in prospective cohorts shows an association between longer telomere length measured phenotypically in peripheral white blood cell (WBC) DNA and increased lung cancer risk. We sought to further explore this relationship by exam
PMID 25516442

Japanese Journal

先進医療と高度医療評価制度と治験

藤原康弘
臨床血液 52(10), 1721-1726, 2011-10-30
NAID 10029769758

Analysis of the Relationships among Graduate Students' Satisfaction, Self-Assessment of Progress, and Research Achievements in Engineering Laboratories

KITAMURA Satoshi,OKAMOTO Eri
Educational technology
… The purpose of this study is to investigate the relationships among graduate students' satisfaction, self-assessment of progress, and research achievements in engineering laboratories. … (2) At a group level, making graduate students participate in joint research would positively correlate with satisfaction in laboratory education and self-assessment of progress. …
NAID 110008749634

「医療技術評価」

　　[★]

英: medical technology assessment MTA
同: メディカル・テクノロジーアセスメント

参考

医療技術評価の使用の国際動向
International Trends in the Use of Health Technology Assessment
費用効率の検討を活用して新しい医薬品や医療技術の相対価値を評価する医療技術評価(HTA)は、償還すべき治療法を償還当局が決定する上で重要な役割を担うものである。オーストラリア、カナダ、及びヨーロッパ諸国の大半の償還当局は、ここ数年間、その償還決定にHTAを利用してきたし、今や多くの国がそれに続いている。重要なことに、アメリカの支払者も、償還決定におけるHTAの可能性に興味を持ち始めている。

http://www.dresources.jp/servis/spectrum/2007/H4-15.html　より引用